Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Presentation at Singapore Conference

20 Sep 2012 07:00

RNS Number : 6887M
ViaLogy PLC
20 September 2012
 



VIALOGY PLC ("VIALOGY")

VIALOGY PRESENTS NEW CAPABILITY FOR INCREASING PRIMARY RECOVERY

IN TIGHT CARBONATES AT AAPG SINGAPORE CONFERENCE

 

Pasadena, CA, September 20, 2012. ViaLogy PLC (LSE/AIM: VIY).At a major international energy industry conference today, ViaLogy presented results of work performed for Chevron showing how QuantumRD, its proprietary seismic analysis technology, could significantly increase primary recovery of oil over currently achieved yields in tight carbonate formations. The Chevron-approved presentation to the American Association of Petroleum Geologists (AAPG) in Singapore also provided more details about ViaLogy's current analysis work for the energy supermajor.

In an extensive test analysis, completed earlier this year, ViaLogy's QuantumRD technology was applied to a Chevron 3D seismic dataset to delineate porosity trends in the tight dolomite formations of the lower Permian Basin. The ability to predict effective carbonate porosity in such formations is central to positioning wells and geosteering for horizontal wells. In the blinded test, QuantumRD located the porosity trend that corresponded to the highest producing wells in the formation, something not previously achieved by using best-of-breed conventional analysis or geostatistical software. ViaLogy actually predicted porosity 2 to 3 miles away from known wells, using information that was below the resolution of the seismic data, and that was verified by comparison with the ground truth derived from over 300 wells in the project area.

Other conclusions from the study presented in Singapore were porosity prediction at 20 feet vertical resolution representing a twofold increase in resolution over conventional inversion and geostatistical techniques applied to similar formations.

Utilizing the QuantumRD method could result in a significant reduction of the number of infill wells drilled using standard gridding techniques while increasing recovery from optimally placed wells, thus saving considerable capital expenditure costs. In fact, the study concluded that 40% of poorly performing wells or dry holes drilled using grid-based placement could have been avoided.

ViaLogy CEO Dr. Robert Dean commented, "We regard the results of our work for Chevron as a very important step in establishing QuantumRD as a technology that will be of great value to the upstream Exploration and Production sector. We believe it to be a key improvement over available techniques, and that its widespread use could achieve major savings in the development and production cycle. The dollar value of QuantumRD is to improve primary yields from production areas such as the Permian Basin that are comprised of multiple tight zones. Also importantly, QuantumRD processing could infuse new life into older, expensively acquired seismic surveys that are known to hold promise for large reserves. ViaLogy is dedicated to realizing this potential. Our current work for Chevron and other companies should provide more examples of operating efficiencies in the coming months."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner, Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMLVLZGZZM
Date   Source Headline
7th Feb 20177:00 amRNSSouthern Europe Business Update
10th Jan 20173:33 pmRNSResult of General Meeting
10th Jan 20177:15 amRNSHardman Research: Yourgene improves growth
21st Dec 20164:00 pmRNSPosting of Circular
21st Dec 20167:00 amRNSHalf year results
21st Dec 20167:00 amRNSConditional Acquisition of Yourgene Bioscience
21st Nov 20167:00 amRNSPremaitha establishes first service lab in Asia
31st Oct 20167:00 amRNSPremaitha welcomes UK Govt. decision on NIPT
27th Oct 20164:10 pmRNSResult of AGM
27th Oct 20167:00 amRNSAGM Statement
21st Oct 20167:00 amRNSGrant of Options
3rd Oct 20167:15 amRNSHardman Research: Excellent first year for IONA®
30th Sep 20163:38 pmRNSNotice of AGM
30th Sep 20167:00 amRNSFinal Results
23rd Sep 201610:42 amRNSHolding(s) in Company
23rd Sep 20168:50 amRNSNotice of results & appointment of broker
23rd Sep 20168:50 amRNSInvestment agreement extension with Thermo Fisher
8th Sep 20169:08 amRNSDirectorate Change
6th Jul 20167:00 amRNSDirectorate Change
4th Jul 20167:00 amRNSProgress on anti-trust objections to litigation
22nd Jun 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
22nd Apr 201610:45 amRNSUpdate on competitor patent litigation
20th Apr 201611:14 amRNSHardman Research: IONA sales & litigation update
20th Apr 20167:00 amRNSPatent Litigation Rescheduled
18th Apr 20161:13 pmRNSHardman & Co Issues Research Report
18th Apr 20161:03 pmRNSHardman & Co Issues Research Report
14th Apr 20167:00 amRNSHolding(s) in Company
13th Apr 20169:52 amRNSHolding(s) in Company
13th Apr 20167:00 amRNSHoldings in Company, Director's Shareholding
11th Apr 20167:00 amRNSTrading Update
29th Mar 20167:00 amRNSPremaitha announces tenth customer laboratory
21st Mar 20167:00 amRNSDistribution Agreements in the Middle East
9th Mar 20165:21 pmRNSHolding in Company, Directors' Dealing Replacement
9th Mar 20163:33 pmRNSHolding in Company, Directors' Dealings
9th Mar 20167:00 amRNSDistribution Agreement with GeNext - Russia
7th Mar 20167:00 amRNSAppointment of Joint Broker
3rd Feb 20167:00 amRNSPremaitha partners with Visional Medical in India
2nd Feb 20167:00 amRNSPremaitha partners with Leeds Hospitals NHS Trust
28th Jan 20167:00 amRNSHardman & Co Research Report: IONA®-Up and running
27th Jan 20167:00 amRNSTwo new customers signed for clinical lab service
26th Jan 20162:29 pmRNSUpdate on UK Litigation Timing
15th Jan 20167:00 amRNSPremaitha welcomes NSC recommendation on NIPT
8th Jan 201612:40 pmRNSUpdate on competitor patent litigation
18th Dec 20157:00 amRNSDirector/PDMR Shareholding
16th Dec 20155:53 pmRNSHolding(s) in Company
15th Dec 20157:00 amRNSHardman Issues Research Report
14th Dec 20157:00 amRNSInvestment Agreement with Thermo Fisher Scientific
14th Dec 20157:00 amRNSHalf Yearly Report
11th Dec 20157:00 amRNSNotice of Half Year Results
2nd Dec 20157:00 amRNSFirst IONA® testing service in France at LaboSud

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.